Literature DB >> 17933794

The C. elegans CBFbeta homologue BRO-1 interacts with the Runx factor, RNT-1, to promote stem cell proliferation and self-renewal.

Hiroshi Kagoshima1, Rachael Nimmo, Nicole Saad, Junko Tanaka, Yoshihiro Miwa, Shohei Mitani, Yuji Kohara, Alison Woollard.   

Abstract

In this report, we investigate the C. elegans CBFbeta homologue, BRO-1. bro-1 mutants have a similar male-specific sensory ray loss phenotype to rnt-1 (the C. elegans homologue of the mammalian CBFbeta-interacting Runx factors), caused by failed cell divisions in the seam lineages. Our studies indicate that BRO-1 and RNT-1 form a cell proliferation-promoting complex, and that BRO-1 increases both the affinity and specificity of RNT-1-DNA interactions. Overexpression of bro-1, like rnt-1, leads to an expansion of seam cell number and co-overexpression of bro-1 and rnt-1 results in massive seam cell hyperplasia. Finally, we find that BRO-1 appears to act independently of RNT-1 in certain situations. These studies provide new insights into the function and regulation of this important cancer-associated DNA-binding complex in stem cells and support the view that Runx/CBFbeta factors have oncogenic potential.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17933794     DOI: 10.1242/dev.008276

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  20 in total

Review 1.  RUNX1-dependent mechanisms in biological control and dysregulation in cancer.

Authors:  Deli Hong; Andrew J Fritz; Jonathan A Gordon; Coralee E Tye; Joseph R Boyd; Kirsten M Tracy; Seth E Frietze; Frances E Carr; Jeffrey A Nickerson; Andre J Van Wijnen; Anthony N Imbalzano; Sayyed K Zaidi; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2018-12-04       Impact factor: 6.384

2.  Control of stem cell self-renewal and differentiation by the heterochronic genes and the cellular asymmetry machinery in Caenorhabditis elegans.

Authors:  Omid F Harandi; Victor R Ambros
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-05       Impact factor: 11.205

3.  Phosphorylation of RUNX1 by cyclin-dependent kinase reduces direct interaction with HDAC1 and HDAC3.

Authors:  Hong Guo; Alan D Friedman
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

Review 4.  Developmental Control of the Cell Cycle: Insights from Caenorhabditis elegans.

Authors:  Edward T Kipreos; Sander van den Heuvel
Journal:  Genetics       Date:  2019-03       Impact factor: 4.562

5.  Wnt signaling controls the stem cell-like asymmetric division of the epithelial seam cells during C. elegans larval development.

Authors:  Julie E Gleason; David M Eisenmann
Journal:  Dev Biol       Date:  2010-09-16       Impact factor: 3.582

6.  A molecular wound response program associated with regeneration initiation in planarians.

Authors:  Danielle Wenemoser; Sylvain W Lapan; Alex W Wilkinson; George W Bell; Peter W Reddien
Journal:  Genes Dev       Date:  2012-05-01       Impact factor: 11.361

7.  CBFbeta is critical for AML1-ETO and TEL-AML1 activity.

Authors:  Liya Roudaia; Matthew D Cheney; Ekaterina Manuylova; Wei Chen; Michelle Morrow; Sangho Park; Chung-Tsai Lee; Prabhjot Kaur; Owen Williams; John H Bushweller; Nancy A Speck
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

Review 8.  Cell cycle and developmental control of hematopoiesis by Runx1.

Authors:  Alan D Friedman
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

Review 9.  The Caenorhabditis elegans epidermis as a model skin. I: development, patterning, and growth.

Authors:  Andrew D Chisholm; Tiffany I Hsiao
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012-06-19       Impact factor: 5.814

10.  The nuclear receptor NHR-25 cooperates with the Wnt/beta-catenin asymmetry pathway to control differentiation of the T seam cell in C. elegans.

Authors:  Martina Hajduskova; Marek Jindra; Michael A Herman; Masako Asahina
Journal:  J Cell Sci       Date:  2009-08-04       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.